血小板輸血
WordNet
- the introduction of blood or blood plasma into a vein or artery (同)blood_transfusion
- the action of pouring a liquid from one vessel to another
PrepTutorEJDIC
- 輸血
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 血小板輸血療法の臨床上および検査上の特徴clinical and laboratory aspects of platelet transfusion therapy [show details]
…platelet use and the indications for platelet transfusion in adults. The approach to the bleeding patient, refractoriness to platelet transfusion, and platelet transfusion in neonates are discussed separately …
- 2. 血小板輸血療法に対する不応性refractoriness to platelet transfusion therapy [show details]
…alloimmune refractoriness to platelet transfusion will be reviewed here. General issues related to platelet transfusion are discussed separately. Refractoriness to platelet transfusion is often multifactorial …
- 3. 重症患者における血液製剤の使用use of blood products in the critically ill [show details]
…for platelet transfusion that are generally seen outside of intensive care unit (ICU) are described separately. Special consideration needs to be given to the indication for platelet transfusion in the …
- 4. 新生児血小板減少症:臨床症状、評価、マネージメントneonatal thrombocytopenia clinical manifestations evaluation and management [show details]
…thrombocytopenia). Platelet transfusion is the primary general intervention administered to infants who are actively bleeding or at-risk for significant bleeding . Platelet transfusions are provided to …
- 5. 造血細胞移植後の造血の促進hematopoietic support after hematopoietic cell transplantation [show details]
…separately. Patients who are thrombocytopenic with bleeding require platelet transfusions. The role of prophylactic platelet transfusions remains controversial. We generally transfuse for platelet counts …
English Journal
- Platelets Apoptosis and Clearance in The Presence of Sodium Octanoate during Storage of Platelet Concentrate at 4˚C.
- Baghdadi V, Yari F, Nikougoftar M, Rafiee MH.
- Cell journal. 2020 Jul;22(2)212-217.
- Platelet (PLT) storage at 4˚C has several benefits, however, it is accompanied by increased clearance of PLTs after transfusion. In this study, we evaluated the potential of sodium octanoate (SO) for reducing apoptosis and clearance rate of PLTs after long-term storage in cold. In this experimental
- PMID 31721536
- Early low molecular weight heparin for postpartum hemorrhage in women with pre-eclampsia. Is it effective to prevent consumptive coagulopathy?
- Kilicci C, Ozkaya E, Karakus R, Sanverdi I, Abide Yayla C, Bostanci Ergen E, Mutlu S.
- The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2020 Feb;33(3)410-414.
- Array Array
- PMID 30189766
- Proteomic analysis of extracellular vesicles derived from platelet concentrates treated with Mirasol® identifies biomarkers of platelet storage lesion.
- Hermida-Nogueira L, Barrachina MN, Izquierdo I, García-Vence M, Lacerenza S, Bravo S, Castrillo A, García Á.
- Journal of proteomics. 2020 Jan;210()103529.
- In blood banks, platelets are stored until 7 days after a pathogen reduction technology (PRT) treatment, Mirasol® (vitamin B plus UVB light) in the present case. The storage time under these conditions may have an impact on platelets and their releasate leading to potential adverse reactions foll
- PMID 31605789
Japanese Journal
- UFT/ユーゼル投与により重篤な副作用をきたしたDPD低活性の1例
- 岩本 明美,岸 清志,竹本 大樹,西江 浩,前田 迪郎
- 日本臨床外科学会雑誌 = The journal of the Japan Surgical Association 71(11), 2791-2794, 2010-11-25
- 症例は75歳,男性.StageIIIa直腸癌と診断され,低位前方切除術を施行した.24病日に術後補助化学療法としてUFT/ユーゼルの内服を開始した.口内炎(Grade3)のため7日目に内服を中止.骨髄抑制が増悪し11日目に入院となった.汎血球減少が急速に増悪し,連日G-CSFと血小板輸血,抗生剤投与をおこなった.22日目より増加に転じ,36日目に退院となった.DPD活性は13mol/min/mg …
- NAID 10027749961
- 腹膜透析導入を選択した骨髄不全症候群合併の腎不全患者2症例
- 小林 さつき,倉林 和隆,加家壁 健,小磯 博美,田村 茂生,内藤 美幸,若松 良二,植木 嘉衛
- 日本透析医学会雑誌 = Journal of Japanese Society for Dialysis Therapy 41(2), 139-143, 2008-02-28
- 骨髄異形成症候群(myelodysplatic syndrome;MDS)を始めとする骨髄不全症候群(bone marrow failure syndrome)は,人口の高齢化に伴い患者数が増加している疾患群である.透析導入患者も年々高齢化していることより,今後,血液疾患合併の透析療法導入患者が増加することが予想される.血小板や白血球の減少,機能異常に伴う出血傾向や易感染性などのリスクが懸念される …
- NAID 10021274364
- Thrombocyte Activation Increases with the Degree of Carotid Artery Stenosis
- STOLZ Erwin,OSCHMANN Patrick,POTZSCH Bernd,KRAUS Jorg,KAPS Manfred
- Journal of stroke and cerebrovascular diseases : official publication of the National Stroke Association 11(6), 324-329, 2002-11-01
- NAID 10012279606
Related Links
- A transfusion may be advised when the platelet count is lower than 50 x 10 9 /L such as in the cases of diffuse microvascular bleeding. Platelets must be given as a prophylaxis in patients with very low platelet counts, or individuals experiencing a rapidly falling count.
- Thomas S. Kickler, in Blood Banking and Transfusion Medicine (Second Edition), 2007 Platelet transfusion therapy has improved over the past 2 decades with new methods for collection, storage, and processing of platelets. With the ...
- Given that transfusion itself carries some risk, albeit perhaps only modest, this should be considered in the safety profile of alternative platelet transfusion protocols. Secondly, both studies demonstrated that a therapeutic
★リンクテーブル★
[★]
- 英
- platelet transfusion, thrombocyte transfusion
- 同
- 栓球輸血
- 関
- 血小板
[★]